Stay updated on IMpower131 Atezolizumab Combo in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the IMpower131 Atezolizumab Combo in Advanced NSCLC Clinical Trial page.

Latest updates to the IMpower131 Atezolizumab Combo in Advanced NSCLC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check17 days agoChange DetectedA sitewide NIH notice announces a transition from the term “Artificial Intelligence” to “Super Intelligence” and links to transition updates and FAQs.SummaryDifference0.4%

- Check24 days agoChange DetectedThe ClinicalTrials.gov site footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check31 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1; the study record content remains unchanged.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page's Revision tag updated from v3.6.6 to v3.7.0, indicating a backend site update.SummaryDifference0.1%

- Check73 days agoChange DetectedA new revision entry (v3.6.6) was added to the page history, and the previous v3.6.5 entry was removed. This reflects a backend update to the page's revision history.SummaryDifference0.1%

Stay in the know with updates to IMpower131 Atezolizumab Combo in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMpower131 Atezolizumab Combo in Advanced NSCLC Clinical Trial page.